a>View full text</a
El-Batal A, El-Hendawy H, Faraag A. &lt;i&gt;In silico&lt;/i&gt; and &lt;i&gt;In vitro&lt;/i&gt; cytotoxic effect of prodigiosin-conjugated silver nanoparticles on liver cancer cells (HepG2). BioTechnologia. 2018;98(3):225-243. doi:10.5114/bta.2017.70801
El-Batal, A., El-Hendawy, H., &amp; Faraag, A. (2018). &lt;i&gt;In silico&lt;/i&gt; and &lt;i&gt;In vitro&lt;/i&gt; cytotoxic effect of prodigiosin-conjugated silver nanoparticles on liver cancer cells (HepG2). BioTechnologia, 98(3), 225-243. https://doi.org/10.5114/bta.2017.70801
El-Batal, Ahmed I., Hoda H. El-Hendawy, and Ahmed H. I. Faraag. 2018. "&lt;i&gt;In silico&lt;/i&gt; and &lt;i&gt;In vitro&lt;/i&gt; cytotoxic effect of prodigiosin-conjugated silver nanoparticles on liver cancer cells (HepG2)". BioTechnologia 98 (3): 225-243. doi:10.5114/bta.2017.70801
El-Batal, A., El-Hendawy, H., and Faraag, A. (2018). &lt;i&gt;In silico&lt;/i&gt; and &lt;i&gt;In vitro&lt;/i&gt; cytotoxic effect of prodigiosin-conjugated silver nanoparticles on liver cancer cells (HepG2). BioTechnologia, 98(3), pp.225-243. https://doi.org/10.5114/bta.2017.70801
El-Batal, Ahmed I. et al. "&lt;i&gt;In silico&lt;/i&gt; and &lt;i&gt;In vitro&lt;/i&gt; cytotoxic effect of prodigiosin-conjugated silver nanoparticles on liver cancer cells (HepG2)." BioTechnologia, vol. 98, no. 3, 2018, pp. 225-243. doi:10.5114/bta.2017.70801
